Related by context. All words. (Click for frequent words.) 74 Phase 2b Clinical Trial 74 Aflibercept 73 Meets Primary Endpoint 73 Telbivudine 73 Phase IIb Clinical Trial 72 Pafuramidine 72 TYGACIL 72 Golimumab 72 Investigational Compound 72 Aliskiren 72 Ceftaroline 72 Investigational Treatment 71 Tezampanel 71 Nitazoxanide 71 Phase IIb Trial 71 JAK Inhibitor 71 Maribavir 71 posaconazole 71 Traficet EN 71 Omacetaxine 71 Phase 2b Trial 71 Ozarelix 71 Sapacitabine 71 Talabostat 71 Boceprevir 71 Dalbavancin 71 Universal Flu Vaccine 71 Antitumor Activity 71 YONDELIS 71 MAGE A3 ASCI 71 Civacir 71 Vicriviroc 71 Demonstrates Potent 70 Clinical Trial Results 70 rilonacept 70 ketolide antibiotic 70 Novel Antibiotic 70 Thiovir 70 Pivotal Phase III 70 ACTEMRA TM 70 Phase III Clinical Trial 70 Ridaforolimus 70 Faropenem 70 AEGR 70 radezolid 70 Noxafil 70 Phase 2a Clinical Trial 70 Pazopanib 70 sorafenib Nexavar 70 cethromycin 70 Dapagliflozin 70 Daclizumab 70 mapatumumab 70 Fast Track Status 70 Altastaph 69 Achieves Primary Endpoint 69 PD LID 69 Interferon Beta 69 Mipomersen 69 Phase 2a Trial 69 Phase III Trial 69 Elesclomol 69 Dasatinib 69 Drug Candidate 69 Advanced Melanoma 69 Patient Enrollment 69 Anidulafungin 69 HDAC Inhibitor 69 Methylnaltrexone 69 oral prodrug 69 non nucleoside inhibitor 69 ZOLINZA 69 Valopicitabine 69 CIMZIA TM 69 HCV Protease Inhibitor 69 Disease Progression 69 Patients Treated With 69 Oral Insulin 69 Oritavancin 69 Vernakalant 69 evaluating tivozanib 69 docetaxel Taxotere ® 69 Moxifloxacin 69 neuraminidase inhibitor 69 receptor tyrosine kinase inhibitor 69 forodesine 69 Belimumab 69 Epratuzumab 69 Lubiprostone 69 Fabry Disease 69 Glufosfamide 69 Fidaxomicin 69 Pivotal Phase 69 SCH # 69 fosbretabulin 69 Anthim 68 Anti Tumor 68 Bortezomib 68 tigecycline 68 Pimavanserin 68 Tarceva TM 68 Lenocta 68 Fluconazole 68 Restanza 68 Tipranavir 68 Pivotal Trial 68 Bosutinib 68 BARACLUDE R 68 Bavituximab 68 proteasome inhibitor 68 sorafenib tablets 68 canakinumab 68 Pegylated 68 Completes Patient Enrollment 68 Ecallantide 68 Reverset 68 Febuxostat 68 Ustekinumab 68 Multimeric 68 Plicera 68 daptomycin 68 Orphan Status 68 CYT# potent vascular disrupting 68 Vaccine Adjuvant 68 Exelixis XL# 68 Monoclonal Antibody 68 HuMax CD4 68 NOXAFIL 68 Chronic Hepatitis B 68 pegylated interferon alfa 2a 68 Radezolid 68 MEK Inhibitor 68 ARCOXIA 68 Hsp# Inhibitor 68 Calcitonin 68 HuMax CD# 68 Elvitegravir 68 relapsed MM 68 Protease Inhibitor 68 FDA Accepts 68 BARACLUDE ® 68 Immunotherapeutic 68 Initiates Clinical 68 Preclinical Data 68 NDA Submission 68 Alinia 68 Investigational Agent 68 Romiplostim 68 nucleoside analog 68 Phase III Clinical Trials 68 Tigecycline 68 Liprotamase 68 Chemophase 68 ORENCIA ® 68 Rivaroxaban 68 Infected Patients 68 Prolongs Survival 68 Romidepsin 68 Phase III Pivotal 68 Amphotericin B 68 Lupus Drug 68 Crofelemer 68 Ramoplanin 68 Temsirolimus 68 NXL# 68 Azacitidine 68 PDE4 inhibitor 68 Peginterferon 68 vidofludimus 68 nucleotide analogue 68 Tasimelteon 67 TYZEKA 67 Diabetic Neuropathy 67 lucinactant 67 delafloxacin 67 eltrombopag 67 Laquinimod 67 CCX# B 67 Cancidas 67 Kinase Inhibitor 67 Pemetrexed 67 Chronic Hepatitis C 67 Begins Dosing 67 Pivotal Trials 67 Valortim R 67 midstage clinical 67 BAL# [002] 67 Nilotinib 67 Anti Tumor Activity 67 Tolvaptan 67 Bezielle 67 Severe Sepsis 67 Ambrisentan 67 Presents Preclinical Data 67 Safinamide 67 PRTX 67 Mylan Receives Approval 67 Phase III Trials 67 CCR5 antagonist 67 Receives Orphan Drug Designation 67 Pegloticase 67 polymerase inhibitor 67 intranasal formulation 67 Pivotal Study 67 II Clinical Trial 67 CCR5 mAb 67 doripenem 67 beta 1a 67 ORENCIA R 67 Initiate Phase 67 adalimumab Humira 67 Mycamine 67 selective modulator 67 Entecavir 67 Recombinant Human 67 Decitabine 67 Lupus Nephritis 67 GLYX 67 DORIBAX 67 DermaVir Patch 67 Silodosin 67 Granulocyte Colony Stimulating Factor 67 ceftazidime 67 micafungin 67 Carfilzomib 67 PEGylated Fab fragment 67 Vandetanib 67 Phase 2b Study 67 Telavancin 67 PRT# 67 HoFH 67 alfa 2a 67 PSN# [002] 67 oral rivaroxaban 67 First Patient Dosed 67 RhuDex 67 peripherally acting 67 Teriflunomide 67 Rotavirus Vaccine 67 INCB# [001] 67 Successfully Completes Phase 67 orally administered inhibitor 67 Darunavir 67 Microplasmin 67 Ofatumumab 67 investigational humanized monoclonal antibody 67 Elotuzumab 67 Cetrorelix 67 CEQ# 67 Initiates Clinical Trial 67 Protexia R 67 Pulmonary Arterial Hypertension 67 Potent Antiviral Activity 67 RhuDex ® 67 elotuzumab 67 Cyclosporine 67 reslizumab 67 Mg Usa 67 LT NS# 67 Aptivus ® 67 ALN TTR 67 HQK 67 KRN# 67 Japanese Encephalitis vaccine 67 anidulafungin 67 Pirfenidone 67 LymphoStat B 67 Serdaxin 67 Levofloxacin 67 Myelodysplastic Syndrome MDS 67 Archexin 67 CCX# 67 Ixempra 67 Icatibant 67 Velcade bortezomib 67 Complicated Skin 67 Muraglitazar 67 ISENTRESS 67 huC# DM4 67 Virologic 67 CIMZIA ™ 67 Fondaparinux 67 Xcytrin R 67 Copegus ribavirin 67 Mycophenolate Mofetil 67 Lung Cancer Drug 67 Pradefovir 67 hypereosinophilic syndrome 66 Nexavar ® 66 HCV SPRINT 66 Elagolix 66 oral methylnaltrexone 66 Initiates Phase II 66 STELARA TM 66 EVIZON TM 66 HCV protease inhibitor 66 Multiple Ascending Dose 66 PEG SN# 66 nitazoxanide 66 SPRYCEL ® 66 Single Dose 66 INVEGA ® 66 ONGLYZA ™ 66 SUTENT ® 66 Treatment Naive Patients 66 Doripenem 66 FOLOTYN ® 66 Valortim ® 66 Antiangiogenic 66 GSK# [001] 66 RECOTHROM R 66 Apixaban 66 sodium glucose cotransporter 66 prucalopride 66 Newly Diagnosed Multiple Myeloma 66 Diabetic Macular Edema 66 UPLYSO 66 Panzem R 66 Actemra tocilizumab 66 HCl capsules 66 ELND# 66 Catena ® 66 Tyrosine Kinase Inhibitor 66 Preclinical Study 66 Onconase 66 Therapeutic Vaccine 66 Hepatitis C Virus 66 SinuNase 66 APTIVUS r 66 Oral Calcitonin 66 Teplizumab 66 TBC# 66 Cutaneous T 66 Presents Positive 66 meropenem 66 Dose Ranging Study 66 oral FTY# 66 antibody MAb 66 First Patient Enrolled 66 Zolinza 66 Montelukast 66 Monotherapy 66 NS#/#A protease 66 metastatic RCC 66 Prostate AdenoCarcinoma Treatment 66 Vimpat R 66 Rheumatoid Arthritis Drug 66 LymphoStat B TM 66 Systemic Delivery 66 Combination Treatment 66 Initiates Phase III 66 Mg Uk 66 Hormone Refractory Prostate Cancer 66 Phase Ib clinical 66 GW# [003] 66 Adalimumab 66 Daptomycin 66 Teriparatide 66 JAK inhibitor 66 phase IIb clinical 66 Rasagiline 66 Initiate Clinical Trial 66 Tyrima 66 Gout Drug 66 Pharmacokinetic Study 66 oral dual endothelin 66 Combination Therapy 66 Candesartan 66 Bicifadine 66 viral kinetics 66 Randomized Phase 66 AAG geldanamycin analog 66 Irinotecan 66 direct thrombin inhibitors 66 sitaxsentan 66 Tocilizumab 66 methylnaltrexone 66 thiazolides 66 Tofacitinib 66 riociguat 66 Vaccine Candidate 66 bosutinib 66 telaprevir VX 66 octreotide acetate 66 Phase Ib II 66 BioNumerik 66 Ticagrelor 66 Study Showed 66 icatibant 66 integrase inhibitor 66 Vitaxin 66 ISTODAX ® 66 Antiviral Activity 66 Raltegravir 66 ritonavir boosted 66 Denufosol 66 pharmacokinetic PK study 66 PEGASYS ® 66 Prostate Cancer Vaccine 66 Alemtuzumab 66 Eraxis 66 Everolimus 66 dopamine partial agonist 66 non peptidic protease 66 Pooled Analysis 66 Lacosamide 66 Degarelix 66 Fingolimod 66 Clinical Trial Data 66 cetuximab Erbitux R 66 PKC# 66 Vidofludimus 66 Dose Escalation 66 PDUFA Date 66 cidofovir 66 Tesetaxel 66 Long Term Efficacy 66 CRMD# 66 OMNARIS HFA 66 Olaparib 66 Polymerase Inhibitor 66 Ceflatonin R 66 Satraplatin 66 Dupuytren Contracture 66 pan HDAC inhibitor 66 interferon gamma 1b 66 investigational monoclonal antibody 66 Submits NDA 66 Capecitabine 66 EGFR TKI 66 BCR ABL inhibitor 66 Zenpep 66 DAPT 66 Torisel 66 Confirmatory Phase 66 Novel Mechanism 66 systemic fungal infections 66 Sprycel dasatinib 66 Antitumor 66 Phase 1b Clinical Trial 66 AEG# 66 SinuNase TM 66 Rilonacept 66 albiglutide 66 #D#C# 66 Simulect 66 Personalized Immunotherapy 66 Chronic Myeloid Leukemia 66 R#/MEM # 66 Melphalan 66 5 HT6 receptor 66 plasma kallikrein inhibitor 66 Seliciclib 66 mRCC 66 LAB CGRP 66 NEUGENE 66 EndoTAG TM -1 65 Aclidinium 65 HCV NS5B polymerase 65 Aurora Kinase 65 administered concomitantly 65 iclaprim 65 Virulizin ® 65 chronic HCV infection 65 Linaclotide 65 SNT-MC#/idebenone 65 Valortim 65 OHR/AVR# 65 BAY #-# 65 BRAF inhibitor 65 Blinatumomab 65 Survival Benefit 65 MGd 65 Hydroxyurea 65 Fluvastatin 65 novel oral anticoagulant 65 pegylated interferon alpha 65 Interferon alfa 65 SAR# [004] 65 Perifosine 65 TRX1 65 targeting CD# 65 Ranolazine 65 INCB# [003] 65 ACHN 65 Oral Fingolimod 65 alefacept 65 Prulifloxacin 65 liposomal formulation 65 omega interferon 65 phase IIb trial 65 T#I [002] 65 INTEGRILIN R 65 FluCide 65 Anticancer Agent 65 Zarnestra 65 PEG IFN 65 Alferon N 65 Fluticasone 65 Investigational Drug 65 Combination REOLYSIN R 65 Clevudine 65 Belerofon 65 Clolar ® 65 Hepatitis B Vaccine 65 Alvesco R 65 mcg dose 65 itraconazole 65 Ocrelizumab 65 BENICAR HCT 65 histone deacetylase inhibitor 65 HCV protease 65 Pivotal Clinical Trial 65 HCV polymerase 65 Myocet 65 AA Amyloidosis 65 multi kinase inhibitor 65 tolevamer 65 inhalation powder 65 ISTODAX 65 Vidaza azacitidine 65 Aurexis 65 CCR9 antagonist 65 JAK2 Inhibitor 65 IMiDs ® 65 Pandemic Influenza Vaccine 65 velafermin 65 chimeric monoclonal antibody 65 Reports Preclinical Data 65 Tolamba 65 Itraconazole 65 OncoVEX GM CSF 65 CANCIDAS 65 budesonide foam 65 Factor VIIa 65 Anti TNF 65 Enzyme Replacement Therapy 65 ADP receptor antagonist 65 Granted Orphan Drug 65 vismodegib 65 Ceflatonin 65 HuMax EGFr 65 Vitro Activity 65 cMET 65 basiliximab 65 Fibrin Pad 65 Darusentan 65 virus HCV protease inhibitor 65 Fulvestrant 65 Epivir 65 Albuferon TM 65 Presents Preclinical 65 CYT# QbG# 65 Treatment Naïve 65 elvucitabine 65 Varespladib 65 itraconazole Sporanox 65 azilsartan medoxomil 65 Non inferiority 65 Panzem 65 talabostat 65 Telaprevir VX 65 Copegus ® 65 Lenalidomide 65 Metastatic Colorectal Cancer 65 TLK# 65 vinca alkaloid 65 Respiratory Virus 65 APTIVUS 65 atovaquone 65 lenalidomide Revlimid R 65 Ceftobiprole 65 Linezolid 65 hour bronchodilation 65 TransVax TM 65 ULORIC 65 Posaconazole 65 Nasal Powder 65 Tesamorelin 65 Initiates Enrollment 65 Phase IIB 65 Phase IIb trials 65 Saxagliptin 65 Gleevec resistant 65 Cloretazine 65 JVRS 65 MORAb 65 administered subcutaneously 65 Paliperidone Palmitate 65 humanized monoclonal 65 trabectedin 65 Vascugel 65 Seasonal Influenza Vaccine 65 RNAi Therapeutic 65 cannabinor 65 MabCampath 65 Hedgehog Pathway Inhibitor 65 GTC recombinant human 65 Paraplatin ® 65 Well Tolerated 65 baminercept 65 orally bioavailable 65 Pegasys ® 65 AVP #D# 65 Clofarabine 65 Arimoclomol 65 ONCONASE R 65 Pegylated Interferon 65 Zenvia Phase III 65 sunitinib Sutent 65 retapamulin 65 Investigational Oral 65 CYP#A# substrate 65 BRIM3 65 Deforolimus 65 maximally tolerated dose 65 IMA# 65 Telithromycin 65 docetaxel Taxotere R 65 Inhalation Solution 65 Atopic Dermatitis 65 Dabigatran etexilate 65 Aganocide 65 recurrent glioblastoma multiforme 65 TransVax ™ 65 Rigel R# 65 Acute Ischemic Stroke 65 LymphoStat B belimumab 65 Campath alemtuzumab 65 TELINTRA 65 aripiprazole Abilify 65 Sitagliptin 65 Schizophrenia Drug 65 Sym# 65 Transdermal Patch 65 DCCR 65 Darinaparsin 65 miconazole Lauriad ® 65 CINTREDEKIN BESUDOTOX 65 Genz # 65 Adjunctive Therapy 65 Zalbin 65 quinolone 65 STELARA ® 65 systemic RNAi therapeutic 65 acyclovir Lauriad R 65 huN# DM1 65 Pralatrexate 65 Zoraxel 65 torezolid phosphate 65 Copegus R 65 Adjuvant Treatment 65 Fibrillex TM 65 Halozyme Therapeutics 65 Regeneron Pharma 65 DU #b 65 Antithrombin 65 CD# monoclonal antibody 65 Intravenous Formulation 65 HBV vaccine 65 erlotinib Tarceva ® 65 ANAVEX #-# [001] 65 Epidermal Growth Factor Receptor 65 PrevOnco 65 DOXIL 65 tenofovir emtricitabine 65 rasagiline tablets 65 Guanilib 65 Octreotide 64 imatinib Gleevec ® 64 MYCAMINE 64 alvimopan 64 nalbuphine ER 64 ganetespib 64 Trodusquemine MSI 64 oral ridaforolimus 64 synthetic retinoid 64 Arikace 64 ROTARIX 64 superficial bladder cancer 64 HspE7 64 acetonide FA 64 betamethasone dipropionate #.# 64 REP# 64 pseudobulbar affect PBA 64 Talactoferrin 64 AVASTIN 64 Gleevec imatinib mesylate 64 Second Pivotal Phase 64 Kahalalide F 64 HCV protease inhibitors 64 Solulin 64 HGS ETR2 64 Indacaterol 64 inhibitor RG# 64 ANDA Filing 64 Phase IIA 64 Azathioprine 64 Allovectin 7 R 64 BRIM2 64 ribavirin RBV 64 pegylated 64 Eltrombopag 64 Deferiprone 64 Study Evaluating 64 XYOTAX TM 64 See CLINICAL PHARMACOLOGY 64 Anticancer Compound 64 nitrofurantoin 64 gastrointestinal stromal tumors GIST 64 Peginterferon alfa 2b 64 Viramidine 64 Dendreon Provenge 64 subcutaneously administered 64 trastuzumab Herceptin R 64 echinocandin 64 MKC# MKC# PP 64 MyVax 64 PEGylated interferon beta 1a 64 thalidomide Thalomid 64 oral antiviral 64 Hepatocellular Carcinoma 64 IAP inhibitors 64 ospemifene 64 CG# [003] 64 Pertuzumab 64 Ramelteon 64 oral renin inhibitor 64 Intranasal 64 GLP toxicology studies 64 fluoroquinolone antibiotic 64 Bucindolol 64 transcriptase inhibitor NNRTI 64 Enoxaparin 64 tocilizumab 64 HCV replicon 64 PSMA ADC 64 ARIXTRA R 64 Tygacil 64 rilpivirine 64 nucleotide analog 64 Previously Treated 64 reduce serum phosphate 64 Statistically Significant 64 Trial Evaluating 64 Zalypsis 64 PEGINTRON TM 64 Erlotinib 64 Tamibarotene 64 Benign Prostatic Hyperplasia 64 XYNTHA 64 dalbavancin 64 JNJ Q2 64 tipranavir 64 Hepatitis C Virus HCV 64 Palifosfamide 64 OvaRex R 64 S/GSK# 64 GRN# 64 RhuDex R 64 Bevacizumab 64 Phase #b/#a clinical 64 solithromycin 64 GLPG# 64 Aviptadil 64 PEGylated anti 64 talactoferrin 64 Afatinib 64 Generic Version 64 Fixed Dose 64 lumiliximab 64 CoFactor 64 Renal Cell Carcinoma 64 sunitinib malate 64 Novel Inhibitor 64 aldosterone antagonists 64 Voreloxin 64 MDV# 64 cardio renal 64 Demonstrated Significant 64 Interferon Gamma 64 investigational protease inhibitor 64 recurrent glioma 64 HCV RNA polymerase 64 Novel Compound 64 Filgrastim 64 RAPTIVA 64 PNP inhibitor 64 Demonstrates Significant 64 voriconazole 64 mertansine 64 IND Filing 64 protein tyrosine phosphatase 1B 64 Interferon alpha 64 apricitabine 64 DEB# 64 Genasense ® 64 davunetide intranasal AL 64 Diamyd r 64 antiviral efficacy 64 Vancocin R 64 fenretinide 64 CDP# 64 Androxal ® 64 Engerix B 64 Adult Stem Cell Therapy 64 Malignant Glioma 64 Antiviral 64 IIa Clinical Trial 64 ATHX 64 PREZISTA r 64 Extended Release 64 Tiotropium 64 Lamivudine 64 Tanespimycin 64 Psoriasis Drug 64 bevirimat 64 CTAP# Capsules 64 Symadex 64 Gilead Viread 64 Iloperidone 64 dasatinib Sprycel ® 64 class mGluR5 inhibitor 64 Cholesterol Lowering Drug 64 Nonclinical 64 Gemcitabine 64 Certican 64 lead Aganocide compound 64 systemically administered 64 Hiberix 64 Vfend 64 Eculizumab 64 cefepime 64 Gamunex C 64 Parathyroid Hormone 64 Crizotinib 64 Treated Patients 64 ALN RSV# 64 GATTEX TM 64 samalizumab 64 TMC# [002] 64 Pneumococcal Vaccine 64 PegIntron 64 Enzastaurin 64 NATRECOR R 64 HGS ETR1 mapatumumab 64 Efficacy Trial 64 Dacogen decitabine 64 beta lactam antibiotic 64 BYETTA ® 64 virus HCV 64 decitabine 64 otelixizumab 64 IL# PE#QQR 64 trastuzumab DM1 T DM1 64 Refractory Hodgkin Lymphoma 64 Shows Efficacy 64 IMiDs ® compound 64 Onalta ™ 64 Randomized Clinical Trial 64 peg interferon 64 Formoterol 64 Preclinical Models 64 angiogenesis inhibitor 64 Xanafide 64 vemurafenib 64 MKC# MT 64 JANUVIA 64 VAPRISOL 64 MAXY alpha 64 PROMACTA 64 Small Molecule 64 favorable pharmacokinetic profile 64 Novel Therapeutic 64 Metastatic Melanoma 64 Kepivance 64 tipifarnib 64 Immunogenicity 64 Improved Survival 64 Exenatide 64 Novel Small Molecule 64 Medoxomil 64 glatiramer acetate 64 compound INCB# 64 Loxapine 64 mTOR inhibitor 64 eosinophilic asthma 64 Topical Gel 64 AZILECT R 64 soluble tumor necrosis 64 HEPLISAV TM 64 RAV# 64 Advanced Pancreatic Cancer 64 panitumumab Vectibix 64 immunomodulatory properties 64 Trastuzumab 64 amphotericin B 64 Nexavar sorafenib 64 Phase Ib study 64 Demonstrates Efficacy 64 tenofovir disoproxil fumarate Viread 64 AVONEX ® 64 PROCHYMAL 64 severe hypercholesterolemia 64 invasive candidiasis 64 torezolid 64 Amigal 64 PROSTVAC TM 64 Vilazodone 64 AGILECT R 64 RELOVAIR ™ 64 Relapsing Remitting Multiple Sclerosis 64 BENLYSTA ® 64 Receives Orphan Drug 64 Roflumilast 64 Abiraterone Acetate 64 investigational oral hepatitis C 64 Fodosine 64 Efficacious 64 Pharmacokinetics PK 64 Onyx Pharmaceuticals Announces 64 echinocandins 64 Oral NKTR 64 Novel Oral 64 mGluR5 NAM 64 ARRY # 64 anagrelide 64 immune modulatory 64 Clinical Trial Evaluating 64 PEG Interferon lambda 64 Epilepsy Drug 64 etravirine 64 Oncolytic 64 Hypercholesterolemia 64 gefitinib Iressa 64 ribavirin USP 64 Alocrest 64 ATL# [001] 64 PROVENGE ® 64 Oral Mucositis 64 amprenavir 64 Vaccine Protects Against 64 Expanded Indication 64 ACE Inhibitors 64 MT# MEDI 64 desvenlafaxine succinate 64 gemifloxacin 64 Virulizin R 64 Entry Inhibitor 64 Omalizumab 64 Triolex 64 Glatiramer Acetate 64 ixabepilone 64 Combo Therapy 64 ONCONASE 64 Hepatotoxicity 64 Milestone Payment 64 Captisol Enabled 64 ganciclovir 64 Certolizumab 64 MT#/MEDI-# 64 Bioequivalence 64 Ziprasidone 64 caspofungin 64 abatacept 64 TORISEL 64 ALN HPN 64 phase Ib 64 histone deacetylase HDAC inhibitor 64 Bafetinib 64 JAK inhibitors 64 AZT zidovudine Retrovir 64 Doxil ® 64 methylnaltrexone bromide 64 Atypical Hemolytic Uremic Syndrome 64 cangrelor 64 LibiGel ® 64 FDA Approvals 64 Prospective Randomized 64 FluINsure 64 EOquin TM 64 broad spectrum cephalosporin 64 trodusquemine 64 GSK '# 64 Randomized Double Blind 64 HMG CoA reductase inhibitors 64 Orphan Designation 64 Jevtana 64 protease inhibitor PI 64 Valsartan 64 oral JAK1 64 Saquinavir 64 Sudhir Agrawal D.Phil 64 Azilect ® 64 Atrasentan 64 Receives Approvable Letter 64 Unit Dose Budesonide 64 ImmunoVEX HSV2 64 Platinol ®